🇺🇸 FDA
Patent

US 9962370

Methods of treatment associated with the granulocyte colony-stimulating factor receptor

granted A61KA61K31/40A61K31/4015

Quick answer

US patent 9962370 (Methods of treatment associated with the granulocyte colony-stimulating factor receptor) held by Ligand Pharmaceuticals Incorporated expires Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue May 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/40, A61K31/4015, A61K31/4045, A61K31/41